Nonsteroidal Anti-inflammatory Drug-related Gastrointestinal Bleeding in the Elderly

Greenwald, 2004, Aging, the gastrointestinal tract, and risk of acid-related disease, Am J Med, 117, 8S Lassen, 2006, Complicated and uncomplicated peptic ulcers in a Danish county 1993-2002: a population-based cohort study, Am J Gastroenterol, 101, 945, 10.1111/j.1572-0241.2006.00518.x Garcia Rodriguez, 1994, Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs, Lancet, 343, 769, 10.1016/S0140-6736(94)91843-0 Griffin, 1991, Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons, Ann Intern Med, 114, 257, 10.7326/0003-4819-114-4-257 Solomon, 2003, The hidden cost of nonselective nonsteroidal antiinflammatory drugs in older patients, J Rheumatol, 30, 792 Terrell, 2006, Prescribing to older ED patients, Am J Emerg Med, 24, 468, 10.1016/j.ajem.2006.01.016 Wolfe, 1999, Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs, N Engl J Med, 340, 1888, 10.1056/NEJM199906173402407 Linder, 2001, Acid peptic disease in the elderly, Gastroenterol Clin North Am, 30, 363, 10.1016/S0889-8553(05)70186-2 Papatheodoridis, 2006, Effects of Helicobacter pylori and nonsteroidal antiinflammatory drugs on peptic ulcer disease: a systematic review, Clin Gastroenterol Hepatol, 4, 130, 10.1016/j.cgh.2005.10.006 Allen, 2005, Gastroduodenal mucus bicarbonate barrier: protection against acid and pepsin, Am J Physiol Cell Physiol, 288, C1, 10.1152/ajpcell.00102.2004 Halter, 1988, Mechanism of gastrointestinal toxicity of NSAIDs, Scand J Rheumatol Suppl, 73, 16, 10.3109/03009748809104664 Cryer, 2001, Mucosal defense and repair. Role of prostaglandins in the stomach and duodenum, Gastroenterol Clin North Am, 30, 877, 10.1016/S0889-8553(05)70218-1 Wilson, 1991, Role of prostaglandins in gastroduodenal mucosal protection, J Clin Gastroenterol, 13, S65, 10.1097/00004836-199112001-00011 Arya, 2002, Prevention of NSAID-related gastrointestinal complications in the geriatric patient, Geriatr Aging, 5, 28 Haykey, 2000, Nonsteroidal anti-inflammatory drug gastropathy, Gastroenterology, 119, 521, 10.1053/gast.2000.9561 Choudari, 1994, The outcome of peptic ulcer haemorrhage in relation to consumption of nonsteroidal anti-inflammatory drugs or aspirin, Aliment Pharmacol Ther, 8, 457, 10.1111/j.1365-2036.1994.tb00314.x Ng, 2006, Incidence and predictors of upper gastrointestinal bleeding in patients receiving low-dose aspirin for secondary prevention of cardiovascular events in patients with coronary artery disease, World J Gastroenterol, 12, 2923, 10.3748/wjg.v12.i18.2923 Laine, 2001, Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patient, Gastroenterology, 120, 594, 10.1053/gast.2001.21907 Armstrong, 1987, Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration, Gut, 28, 527, 10.1136/gut.28.5.527 Gabriel, 1991, Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis, Ann Intern Med, 115, 787, 10.7326/0003-4819-115-10-787 Geyer, 2006, Epidemiology of gastrointestinal bleeding in the elderly, Schweiz Rundsch Med Prax, 95, 757 Hallas, 1995, Nonsteroidal anti-inflammatory drugs and upper gastrointestinal bleeding, identifying high-risk groups by excess risk estimates, Scand J Gastroenterol, 30, 438, 10.3109/00365529509093304 Mitchell, 2004, A new view of occult and obscure gastrointestinal bleeding, Am Fam Physician, 69, 875 Hayashi, 2005, Non-steroidal anti-inflammatory drug-induced small bowel injuries identified by double-balloon endoscopy, World J Gastroenterol, 11, 4861, 10.3748/wjg.v11.i31.4861 Meddings, 1993, Sucrose: a novel permeability marker for gastroduodenal disease, Gastroenterology, 104, 1619, 10.1016/0016-5085(93)90637-R Rabassa, 1996, Effects of aspirin and Helicobacter pylori on the gastroduodenal mucosal permeability to sucrose, Gut, 39, 159, 10.1136/gut.39.2.159 Goldstein, 2006, A multicenter, randomized, doubleblind, active-comparator, placebo-controlled, parallelgroup comparison of the incidence of endoscopic gastric and duodenal ulcer rates with valdecoxib or naproxen in healthy subjects aged 65 to 75 years, Clin Ther, 28, 340, 10.1016/j.clinthera.2006.03.007 Pilotto, 2005, Upper gastrointestinal symptoms and therapies in elderly out-patients, users of non-selective NSAIDs or coxibs, Aliment Pharmacol Ther, 22, 147, 10.1111/j.1365-2036.2005.02537.x Scheiman, 2006, Unmet needs in non-steroidal antiinflammatory drug-induced upper gastrointestinal diseases, Drugs, 66, 15, 10.2165/00003495-200666001-00004 Cozzarini, 2003, Mucosa protective therapy with longterm nonsteroidal antirheumatic drugs, Wien Med Wochenschr, 153, 295, 10.1046/j.1563-258X.2003.03035.x Sung, 2001, Management of nonsteroidal anti-inflammatory drug-related peptic ulcer bleeding, Am J Med, 110, 29S, 10.1016/S0002-9343(00)00633-1 Caldwell, 1987, Sucralfate treatment of nonsteroidal anti-inflammatory drug-induced gastrointestinal symptoms and mucosal damage, Am J Med, 83, 74, 10.1016/0002-9343(87)90832-1 Miglioli, 1996, Prevention with sucralfate gel of NSAID-induced gastroduodenal damage in arthritic patients, Am J Gastroenterol, 91, 2367 Kurosawa, 2002, What is important in treating elderly with H2 receptor antagonists, Nippon Rinsho, 60, 1613 Lanas, 2003, Low frequency of upper gastrointestinal complications in a cohort of high-risk patients taking low-dose aspirin or NSAIDS and omeprazole, Scand J Gastroenterol, 38, 693, 10.1080/00365520310003967 Lanas, 2006, NSAID-induced gastrointestinal damage: current clinical management and recommendations for prevention, Chin J Dig Dis, 7, 127, 10.1111/j.1443-9573.2006.00257.x Pilotto, 2004, Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal antiinflammatory drugs, Aliment Pharmacol Ther, 20, 1091, 10.1111/j.1365-2036.2004.02246.x Chan, 2001, Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen, N Engl J Med, 344, 967, 10.1056/NEJM200103293441304 Gisbert, 2004, Meta-analysis: Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer, Aliment Pharmacol Ther, 19, 617, 10.1111/j.1365-2036.2004.01898.x Giral, 2004, Effect of Helicobacter pylori eradication on antithrombotic dose aspirin-induced gastroduodenal mucosal injury, J Gastroenterol Hepatol, 19, 773, 10.1111/j.1440-1746.2004.03374.x Hunt, 2004, Review article: should NSAID/lowdose aspirin takers be tested routinely for H. pylori infection and treated if positive? Implications for primary risk of ulcer and ulcer relapse after initial healing, Aliment Pharmacol Ther, 19, 9, 10.1111/j.0953-0673.2004.01830.x Chan, 2005, NSAID-induced peptic ulcers and Helicobacter pylori infection: implications for patient management, Drug Saf, 28, 287, 10.2165/00002018-200528040-00002